[HTML][HTML] Changes in salivary parameters of oral immunity after biologic therapy for inflammatory bowel disease
K Nijakowski, R Rutkowski, P Eder, K Korybalska… - Life, 2021 - mdpi.com
We previously observed that inflammatory bowel disease (IBD) may compromise oral host
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
[PDF][PDF] Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease
K Nijakowski, R Rutkowski, P Eder, K Korybalska… - Life, 2021 - academia.edu
We previously observed that inflammatory bowel disease (IBD) may compromise oral host
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease.
K Nijakowski, R Rutkowski, P Eder… - Life (Basel …, 2021 - europepmc.org
We previously observed that inflammatory bowel disease (IBD) may compromise oral host
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease
K Nijakowski, R Rutkowski, P Eder, K Korybalska… - Life, 2021 - search.proquest.com
We previously observed that inflammatory bowel disease (IBD) may compromise oral host
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease.
K Nijakowski, R Rutkowski, P Eder… - Life (2075 …, 2021 - search.ebscohost.com
We previously observed that inflammatory bowel disease (IBD) may compromise oral host
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease
K Nijakowski, R Rutkowski, P Eder… - Life (Basel …, 2021 - pubmed.ncbi.nlm.nih.gov
We previously observed that inflammatory bowel disease (IBD) may compromise oral host
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
[HTML][HTML] Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease
K Nijakowski, R Rutkowski, P Eder, K Korybalska… - Life, 2021 - ncbi.nlm.nih.gov
We previously observed that inflammatory bowel disease (IBD) may compromise oral host
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease
K Nijakowski, R Rutkowski, P Eder, K Korybalska… - agris.fao.org
We previously observed that inflammatory bowel disease (IBD) may compromise oral host
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease
K Nijakowski, R Rutkowski, P Eder, K Korybalska… - Life, 2021 - ui.adsabs.harvard.edu
We previously observed that inflammatory bowel disease (IBD) may compromise oral host
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …
defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and …